Veterinary Medicines

Selevitam opl. pro inj.

Authorised
  • SODIUM SELENITE ANHYDROUS
  • DL-ALPHA-TOCOPHEROL
Download as PDF

Product identification

Medicine name:
Selevitam opl. pro inj.
Active substance:
  • SODIUM SELENITE ANHYDROUS
  • DL-ALPHA-TOCOPHEROL
Target species:
  • Cattle (calf)
  • Sheep (lamb)
  • Pig
  • Pig (piglet)
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • SODIUM SELENITE ANHYDROUS
    0.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • DL-ALPHA-TOCOPHEROL
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Pig (piglet)
      • Meat and offal
        0
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11JC
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • A.A.-Vet Diergeneesmiddelen N.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • A.A.-Vet Diergeneesmiddelen N.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 5123
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 5/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."